141 related articles for article (PubMed ID: 23452182)
1. Aldo-keto reductase and sorbitol dehydrogenase enzymes in Egyptian diabetic patients with and without proliferative diabetic retinopathy.
Aldebasi Y; El-Gendy SM; Kamel A; Mohieldein A
Clin Exp Optom; 2013 May; 96(3):303-9. PubMed ID: 23452182
[TBL] [Abstract][Full Text] [Related]
2. Association study of sorbitol dehydrogenase -888G>C polymorphism with type 2 diabetic retinopathy in Caucasian-Brazilians.
Ferreira FN; Crispim D; Canani LH; Gross JL; dos Santos KG
Exp Eye Res; 2013 Oct; 115():140-3. PubMed ID: 23850972
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in Sorbitol-Aldose Reductase (Polyol) Pathway Genes and Their Influence on Risk of Diabetic Retinopathy Among Han Chinese.
Li W; Chen S; Mei Z; Zhao F; Xiang Y
Med Sci Monit; 2019 Sep; 25():7073-7078. PubMed ID: 31539366
[TBL] [Abstract][Full Text] [Related]
4. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of sorbitol dehydrogenase (SDH) gene and susceptibility to diabetic retinopathy.
Amano S; Yamagishi S; Koda Y; Tsuneoka M; Soejima M; Okamoto T; Inagaki Y; Yamada K; Kimura H
Med Hypotheses; 2003 Apr; 60(4):550-1. PubMed ID: 12615520
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy.
Reddy GB; Satyanarayana A; Balakrishna N; Ayyagari R; Padma M; Viswanath K; Petrash JM
Mol Vis; 2008 Mar; 14():593-601. PubMed ID: 18385795
[TBL] [Abstract][Full Text] [Related]
7. Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes.
Amano S; Yamagishi Si; Kato N; Inagaki Y; Okamoto T; Makino M; Taniko K; Hirooka H; Jomori T; Takeuchi M
Biochem Biophys Res Commun; 2002 Nov; 299(2):183-8. PubMed ID: 12437967
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte sorbitol dehydrogenase activity in diabetic patients.
De Leeuw IH; Vertommen JJ; Rillaerts EG
Diabetes Res Clin Pract; 1993 Apr; 20(1):51-4. PubMed ID: 8344129
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase and diabetic retinopathy.
Singh R; Dash D; Ansari FJ; Maurya OP; Singh VP
Ann Ophthalmol; 1992 Nov; 24(11):420-2. PubMed ID: 1476398
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues.
Preet A; Siddiqui MR; Taha A; Badhai J; Hussain ME; Yadava PK; Baquer NZ
Mol Cell Biochem; 2006 Sep; 289(1-2):137-47. PubMed ID: 16718375
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study.
Sardarinia M; Asgari S; Hizomi Arani R; Eskandari F; Azizi F; Khalili D; Hadaegh F
J Diabetes Investig; 2022 Feb; 13(2):317-327. PubMed ID: 34403198
[TBL] [Abstract][Full Text] [Related]
12. Serum Pentraxin 3 level as a recent biomarker of diabetic retinopathy in Egyptian patients with diabetes.
Elbana KA; Salem HM; Abdel Fattah NR; Etman E
Diabetes Metab Syndr; 2019; 13(4):2361-2364. PubMed ID: 31405644
[TBL] [Abstract][Full Text] [Related]
13. Vascular responsiveness in type 2 diabetes mellitus (T2DM).
Blum A; Socea D; Sirchan R
QJM; 2016 Dec; 109(12):791-796. PubMed ID: 27289111
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between serum sialic acid levels and retinopathy in Type 2 diabetic patients.
Deepa R; Rema M; Mohan V
Diabetes Res Clin Pract; 1998 Sep; 41(3):165-9. PubMed ID: 9829344
[TBL] [Abstract][Full Text] [Related]
15. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency.
Ii S; Ohta M; Kudo E; Yamaoka T; Tachikawa T; Moritani M; Itakura M; Yoshimoto K
Diabetologia; 2004 Mar; 47(3):541-548. PubMed ID: 14968292
[TBL] [Abstract][Full Text] [Related]
16. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
Ozmen B; Boyvada S
J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
[TBL] [Abstract][Full Text] [Related]
17. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.
Hu A; Luo Y; Li T; Guo X; Ding X; Zhu X; Wang X; Tang S
Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):957-62. PubMed ID: 22327732
[TBL] [Abstract][Full Text] [Related]
18. Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders.
Janghorbani M; Jones RB; Allison SP
Ophthalmic Epidemiol; 2000 Dec; 7(4):225-41. PubMed ID: 11262670
[TBL] [Abstract][Full Text] [Related]
19. Plasma sorbitol dehydrogenase in diabetic subjects with or without vascular complications.
Sgambato S; Ceriello A; Passariello N; Giuliano D
Biochem Exp Biol; 1979; 15(1):61-4. PubMed ID: 548122
[TBL] [Abstract][Full Text] [Related]
20. Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors.
Madhu SV; Verma NP; Goel A; Kapoor VK
J Assoc Physicians India; 1992 Oct; 40(10):679-81. PubMed ID: 1307356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
